• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Mads Krogsgaard Thomsen - Articles and news items

Novo Nordisk Logo

NovoEight® passed the review by the Committee on Drugs of Pharmaceutical Affairs in Japan

Industry news / 18 November 2013 / Novo Nordisk

NovoEight® has passed the review by the Committee on Drugs of Japan’s Pharmaceutical Affairs and Sanitation Council…

Novo Nordisk Logo

Novo Nordisk receives FDA approval for FlexTouch® in the US

Industry news / 1 November 2013 / Novo Nordisk

FlexTouch® is the latest innovation in prefilled insulin delivery systems from Novo Nordisk…

Novo Nordisk Logo

Novoeight® (turoctocog alfa) receives approval from the FDA

Industry news / 16 October 2013 / Novo Nordisk

“The approval of Novoeight® marks an important step in offering a new alternative for people with haemophilia A…”

Novo Nordisk Logo
Novo Nordisk Logo

People with type 2 diabetes achieve 6% weight loss with liraglutide 3 mg in phase 3a obesity trial

Industry news, News / 18 March 2013 / Novo Nordisk

Novo Nordisk announced the headline results from a 56-week, double-blind phase 3a clinical trial…

Novo Nordisk Logo

Tresiba® and Ryzodeg® receive marketing authorisations in Europe

Industry news, News / 21 January 2013 / Novo Nordisk

“We look forward to making Tresiba® and Ryzodeg® available to many people with diabetes in Europe”

Novo Nordisk Logo

Insulin degludec and insulin degludec/insulin aspart receive positive vote for approval

Industry news, News / 9 November 2012 / Novo Nordisk

“The positive vote from the Advisory Committee marks an important step…”

Novo Nordisk Logo

Tresiba® and Ryzodeg® receive positive opinions from the European regulatory authorities

Industry news, News / 19 October 2012 / Novo Nordisk

Tresiba® and Ryzodeg® receive positive opinions…

Novo Nordisk Logo

Novo Nordisk files for regulatory approval of turoctocog alfa for haemophilia A in the US and EU

Industry news, News / 16 October 2012 / Novo Nordisk

Novo Nordisk announced the submission of the regulatory application for turoctocog alfa…

Novo Nordisk Logo

Novo Nordisk to initiate phase 3 development of semaglutide

Industry news, News / 21 June 2012 / Novo Nordisk

The decision to initiate the global phase 3 development programme for semaglutide announced…

Novo Nordisk Logo

JDRF and Novo Nordisk establish R&D collaboration in type 1 diabetes

Industry news, News / 13 June 2012 / Novo Nordisk

Focus will be on disease-modifying immunotherapies for type 1 diabetes…

Novo Nordisk Logo

Novo Nordisk receives positive opinion on recombinant factor XIII from the European regulatory authorities

Industry news, News / 25 May 2012 / Novo Nordisk

Novo Nordisk receives a positive opinion on recombinant factor XIII product (rFXIII)…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +